Philippe Pierre Goupit
Président chez Tollys
Provenance du réseau au premier degré de Philippe Pierre Goupit
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
122
| Public Company | Biotechnology | 122 |
MedDay Pharmaceuticals SAS
 MedDay Pharmaceuticals SAS BiotechnologyHealth Technology MedDay Pharmaceuticals SAS operates as a biotechnology company developing new drugs for nervous system disorders. The firm operates for the treatment of neuro-metabolic diseases. The company was founded by Frédéric Sedel and Guillaume Brion in 2011 and is headquartered in Paris, France.
6
| Holding Company | Biotechnology | 6 |
Tollys
 Tollys Hospital/Nursing ManagementHealth Services Tollys is a French company that specializes in developing clinical-grade TLR3 ligands for cancer immunotherapy. The company is based in Lyon, France and was founded by Dominique Rigal. The company's co-founders discovered that TLR3 agonists have the potential to induce direct and immunogenic tumor cell death while sparing normal cells. Tollys has filled a patent for a new family of TLR3 ligands and confirmed freedom to operate. The CEO is Vincent Charlon.
5
| Holding Company | Hospital/Nursing Management | 5 |
| Public Company | Biotechnology | 3 | |
Fovea Pharmaceuticals SA
 Fovea Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Fovea operates within the ophthalmic pharmaceutical market, which is expected to grow at a double-digit annual rate during the years to come. This growth is likely to be driven by new technologies and products, premium pricing facing no significant reimbursement issues, favorable trends (aging of the population, diabetes epidemiology and environmental factors) and dramatic expansion into the large and mostly untapped market for retinal degenerative diseases. With a limited number of players, the ophthalmology market has proved recently to be an early adopter of innovations, allowing new players to gain visibility very rapidly. During the last three years, Fovea has implemented this strategy, by acquiring products from large pharmaceutical or biotech companies and is actively developing them in four different indications. It has also integrated a unique drug discovery platform and has been able to identify one preclinical candidate and several interesting new targets.
2
| Extinct | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Philippe Pierre Goupit via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| AXA | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| TOTALENERGIES SE | Integrated Oil | Chairman Corporate Officer/Principal Director of Finance/CFO | |
| 2INVEST AG | Financial Conglomerates | Chairman Director/Board Member | |
| VIVENDI SE | Media Conglomerates | Chairman Chief Executive Officer | |
| ALLIANZ SE | Multi-Line Insurance | Director/Board Member Director/Board Member | |
| TRANSGENE | Biotechnology | Director of Finance/CFO General Counsel | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel President Chief Executive Officer Corporate Officer/Principal Director/Board Member General Counsel | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| L'ORÉAL | Household/Personal Care | Director/Board Member Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Total Holdings SAS
 Total Holdings SAS Wholesale DistributorsDistribution Services Total Holdings SAS provides oil refining and marketing services. The company was founded on October 10, 1955 and is headquartered in Courbevoie, France. | Wholesale Distributors | Chief Executive Officer Director of Finance/CFO Director/Board Member | |
| AIR LIQUIDE | Chemicals: Specialty | Director/Board Member Director/Board Member Director of Finance/CFO | |
| University of Oxford | College/University | Undergraduate Degree Graduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| Queen's University | College/University | Undergraduate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Graduate Degree | |
| INSEAD | College/University | Masters Business Admin Director/Board Member Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
L'Oréal USA, Inc.
 L'Oréal USA, Inc. Medical DistributorsDistribution Services L'Oréal USA, Inc. manufactures and distributes cosmetics, concentrating on hair color, skin care, sun protection, make-up, perfumes, and hair care. The company was founded in 1953 and is headquartered in New York, NY. | Medical Distributors | Chairman Director/Board Member Chief Executive Officer | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Graduate Degree Corporate Officer/Principal | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| ESSEC Business School | College/University | Undergraduate Degree Chief Executive Officer Undergraduate Degree Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Ecole Polytechnique | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| École Nationale Supérieure des Mines de Paris | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Sanofi-Aventis U.S. LLC
 Sanofi-Aventis U.S. LLC Pharmaceuticals: MajorHealth Technology Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | President Director/Board Member | |
| Association Française des Entreprises Privées | Director/Board Member Director/Board Member Director/Board Member | ||
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Biotechnology | Director of Finance/CFO Chief Executive Officer Corporate Officer/Principal | |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Medical Distributors | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| Rhone-Poulenc Group | Chief Executive Officer Chief Executive Officer | ||
Anergis SA
 Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland. | Pharmaceuticals: Generic | Director/Board Member Chairman Chief Executive Officer | |
| L'Oréal Corporate Foundation | Chairman Director/Board Member Director/Board Member | ||
| Alliance for Research & Innovation in Health Industries | Corporate Secretary Corporate Officer/Principal | ||
Brainever SAS
 Brainever SAS Pharmaceuticals: MajorHealth Technology Brainever SAS manufactures pharmaceutical products. It develops medicines for nervous system diseases. The company was founded on March 31, 2015 and is headquartered in Paris, France. | Pharmaceuticals: Major | Director/Board Member Founder | |
DNA Script SAS
 DNA Script SAS Medical SpecialtiesHealth Technology DNA Script engages in the provision of research and development in biotechnology. It manufactures synthetic deoxyribonucleic acid using enzymatic technology. The company was founded by Thomas Ybert, Sylvain Gariel and Xavier Godron in 2014 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member Director of Finance/CFO |
Statistiques
Internationale
| France | 29 |
| Etats-Unis | 13 |
| Royaume-Uni | 4 |
| Allemagne | 3 |
| Suisse | 3 |
Sectorielle
| Health Technology | 22 |
| Consumer Services | 14 |
| Finance | 6 |
| Distribution Services | 4 |
| Energy Minerals | 2 |
Opérationnelle
| Director/Board Member | 510 |
| Corporate Officer/Principal | 247 |
| Chairman | 146 |
| Independent Dir/Board Member | 116 |
| Chief Executive Officer | 96 |
Relations les plus connectées
| Insiders | |
|---|---|
| Serge Weinberg | 49 |
| Chris Buyse | 39 |
| Christopher Viehbacher | 37 |
| Carole Piwnica | 37 |
| Suet-Fern Lee | 36 |
| Pascale Witz | 31 |
| Catherine Moukheibir | 29 |
| Patrick Kron | 28 |
| Fabienne Lecorvaisier | 27 |
| Chahra Khaoua Epouse Louafi | 26 |
| Robert Castaigne | 23 |
| Carsten Hellmann | 22 |
| Jean-René Fourtou | 21 |
| Arthur Charles V. Wellesley | 21 |
| Claudie Haigneré | 20 |
- Bourse
- Insiders
- Philippe Pierre Goupit
- Connexions Sociétés
